Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 9, 2004 - Issue 2
Submit an article Journal homepage
26
Views
4
CrossRef citations to date
0
Altmetric
Review

Antithrombotic trials in acute ischaemic stroke: a selective review

Kathleen M Burger Mount Sinai School of Medicine, 1 Gustave Place Box 1137, New York, NY 10029, USA. [email protected]
&
Stanley Tuhrim Mount Sinai School of Medicine, 1 Gustave Place Box 1137, New York, NY 10029, USA
Pages 303-312 | Published online: 24 Feb 2005

Bibliography

  • GOLDSTEIN L, ADAMS R, BECKER K et al.: Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American heart association. Circulation (2001) 103:163–182.
  • •A comprehensive review of stroke risk factors and management guidelines.
  • ADAMS H, DAVIS P, LEIRA E et al.: Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the trial of org 10172 in acute stoketreatment (TOAST). Neurology (1999) 53:126–131.
  • VON KUMMER R, NOLTE PN, SCHNITTGER H et al.: Detectability of cerebral hemisphere ischaemic infarcts by CT within 6 hours of stroke. Neuroradiology (1996) 38:31–33.
  • ADAMS HP, ADAMS RJ, BROTT T et al.: Guidelines for the early management of patients with ischemic stroke. A scientific statement from the stroke council of the American Stroke Association. Stroke (2003) 34:1056–1083.
  • CADILHAC DA, IBRAHIM J, PEARCE DC et al.: Multicenter comparison of processes of care between stroke units and conventional care wards inAustralia. Stroke (2004) 35:1035–1040.
  • BRODERICK J, BROTT T, KOTHARI R et al.: The Greater Cincinnati/Northern Kentucky Stroke Study. Preliminary first ever and total incidence rates of strokes among blacks. Stroke (1998) 29:415–421.
  • BROWN RD, WHISNANT JP, SICKS JD, O'FALLON WM, WEIBERS DO: Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 27:373–380.
  • BOGOUSSLAVSKY J: William Feinberg Lecture 2002. Emotions, mood, and behavior after stroke. Stroke (2003) 34:1046–1050.
  • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke ft-PA Study Group. N Engl. J. Med. (1995) 333:1581–1587.
  • Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. JAMA (1998) 279:1265–1272.
  • THE INTERNATIONAL STROKE TRIAL (1ST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet (1997) 349:1569–1581.
  • BATH PMW, IDDENDEN R, BATH FJ: Low-molecular-weight heparins and heparinoids in acute ischemic stroke. A meta-analysis of randomized controlled trials. Stroke (2000) 31:1770–1778.
  • MOHR JP, THOMPSON JLP,LAZAR RM et al.: A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl. J. Med. (2001) 345:1444–1451.
  • CHINESE ACUTE STROKE TRIAL COLLABORATIVE GROUP: CAST: randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet (1997) 349:1641–1649.
  • GROTTA J: Combination Therapy Stroke Trial: rt-PA +/- Lebeluzole (abstract). Stroke (2000) 31:278.
  • LYDEN P, JACOBY M, SCHIM G et al.: The clomethiazole acute stroke study in tissue-type plasminogen activator-treated stroke (Class-T): final results. Neurology (2001)57:1199–1205.
  • SACCO R, PHILLIPS S, HALEY E et al.: Efficacy and safety of GV150526 in acute stroke: results of the GAIN Americas Trial (glycine antagonist in neuroprotection) (abstract). Neurology (2000)54\(Suppl. 3):A87.
  • MEYER JS, GILROY J, BARNHART ME et al.: Anticoagulants plus streptokinase therapy in progressive stroke. JAMA (1964) 189:373.
  • DONNAN GA, DAVIS SM,CHAMBERS BR et al.: Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group. JAMA (1996) 276:961–966.
  • Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischemic stroke. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Lancet (1995) 346:1509–1514.
  • Thrombolytic therapy with streptokinase inacute ischemic stroke. The Multicenter Acute Stroke Trial-Europe Study Group. New England Journal of Medidne (1996) 335:145–150.
  • PHAN TG, WIJDICKS EFM: Endovascular therapy and neurocritical care. Intra-arterial thrombolysis for vertebrobasilar circulation ischemia. Critical Care Clinics (1999) 15:719–742.
  • Physicians Desk Reference. 58th Edition. Medical Economics Company, Inc. (2004):1297–1301.
  • KWIATKOWSKI TG, LIBMAN RB, FRANKEL MR et al.: Effects of tissue plasminogen activator for acute ischemic stroke at one year: National Institute of Neurological Disorders and Stroke rt-PA Study Group. N Engl. J. Med. (1999) 340:1781–1787.
  • TANNE D, DEMCHUK AM, DASNER SE et al.: Intravenous thrombolysis for acute ischemic stroke: the Phase IV data. TPA for acute stroke: perspectives after 5 years of use. &min. Cerebrovasc. Dis. (2001) 1:130–140.
  • KATZAN IL, FURLAN AJ, LLOYD LE et al.: Use of tissue-type plasminogen activator for acute ischemic stroke. The Cleveland Area Experience. JAMA (2000) 283:1151–1158.
  • ALBERS G, BATES V, CLARK W, BELL R, VERRO P, HAMILTON S: Intravenous tissue-type plasminogen activator for treatment of acute stroke. The standard treatment with alteplase to reverse stroke (STARS) study. JAMA (2000) 283:1145–1150.
  • HILL M, WOOLFENDEU A, TEAL P et al.: Intravenous alteplase for stroke: the Canadian experience. The StrokeInter ventionalist (2000) 2:3–8.
  • HACKE W, KASTE M, FIESCHI C et al.:Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA (1995) 274:1017–1025.
  • HACKE W, KASTE M, FIESCHI C et al.:Randomized double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australian acute stroke study investigators. Lancet (1998) 352:1245–1251.
  • CLARK W, WISSMAN S, ALBERS G et al.: Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA (1999) 282:2019–2026.
  • FAGAN SC, MORGENSTERN LB, PETITTA A et al.: Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology(1998) 50: 883–890.
  • NEDELTCHEV K, ARNOLD M, BREKENFELD C et al.: Pre- and in-hospital delays from stroke onset to intra-arterial thrombolysis. Stroke (2003) 34:1230–1234.
  • FURLAN A, HIGASHIDA R, WECHSLER L et al.: Intra-arterial Prourokinase for Acute Ischemic Stroke. The PROACT II Study: a randomized controlled trial. JAMA (1999) 282:2003–2011.
  • WECHSLER LR, JUNGREIS CA: Endovascular therapy and neurocritical care. Intra-arterial thrombolysis for carotid circulation ischemia. Crit.Care Clin. (1999) 15:701–718.
  • ZEUMER H, FREITAG HJ, ZANELLA F, THIE A, ARNING C: Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology (1993) 35:159–162.
  • BOUREKAS EC, SLIVKA AP, SHAH R, TARR RW, SUNSHINE J, SUAREZ JI: Intra-arterial thrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery (2004) 54:39–46.
  • BRANDT T, VON KUMMER R, MULLER-KUPPERS M, HACKE W: Thrombolytic therapy of acute basilar artery occlusion. Stroke (1996) 27:875–881.
  • EZAKI Y, TSUTSUMI K, ONIZUKA M et al.: Retrospective analysis of neurological outcome after intra-arterial thrombolysis in basilar artery occlusion. Surg. Neurol (2003) 60:423–430.
  • WARACH S, CHIEN D, LE W et al: Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann. Neurol (1992) 42:1717–1723.
  • DIAS: Presented at the 29th InternationalStroke Conference. San Diego, California. February 2004 (abstract).
  • QURESHI Al, PANDE RU, KIM SH et al.: Third generation thrombolytics for the treatment of ischemic stroke. Curc Opin. Investig. Drugs (2002) 12:1729–1732.
  • LEWANDOWSKI CA, FRANKEL M, TOMSICK TA et al.: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke. Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 30:2598–2605.
  • THE IMS STUDY INVESTIGATORS. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke (2004) 35:904–912.
  • THE ANCROD STUDY INVESTIGATORS. Ancrod for the treatment of acute ischemic brain infarction. Stroke (1994) 25:1755–1759.
  • SHERMAN DG, ATKINSON RP, CHIPPENDALE T et al.: Intravenous ancrod for the treatment of acute ischemic stroke. The STAT Study: a randomized controlled trial. JAMA (2000) 283:2395–2403.
  • THE ABCIXIMAB IN ISCHEMIC STROKE INVESTIGATORS: Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study. Stroke (2000) 31:601–609.
  • ABESTT INVESTIGATORS: Effects of abciximab for acute ischemic stroke: final results of Abciximab in Emergent Stroke Treatment Trial (AbESTT). Stroke (2003) 34:252 (abstract).
  • NAKANO S, ISEDA T, YONEYAMA T, KAWANO H, WAKISAKA S: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to infra-arterial thrombolysis. Stroke (2002) 33:2872–2876.
  • SCHUMACHER HC, MEYERS PM, YAVAGAL DR et al.: Endovascular mechanical thrombectomy of an occluded superior division branch of the left MCA for acute cardioembolic stroke. Cardiovasc. Intervent. Radial. (2003) 26:305–308.
  • DAFFERTSHOFER M, FATAR M: Therapeutic ultrasound in ischemic stroke treatment: experimental evidence. Eur. Ultrasound (2002) 16:121–130.
  • ALEXANDROV AV, DEMCHUK AM, BURGIN WS, ROBINSON DJ, GROTTA JC: Ultrasound-enhanced thrombolysis for acute ischemic stroke: Phase I. Findings of the CLOTBUST trial.Neuroimaging (2004) 14:113–117.
  • EPAR therapy system for treatment of acute stroke: safety study results. 26th International Stroke Conference. Stroke (2001) 32:319-6 (abstract).
  • KIDWELL CS, SAVER JL, MATTIELLO J et al.: Thrombolyfic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann. Neurol (2000) 47:462–469.
  • THE ATLANTIS, ECASS, AND NINDS RT-PA STUDY GROUP INVESTIGATORS: Association ofoutcome with early stroke treatment: pooled analysis of ATLSNTIS, ECASS, and NINDS rt-PA stroke trials. Lancet (2004) 363:768–774.
  • SILVER B, WEBER J, FISHER M et al.: Medical therapy for acute ischemic stroke. Clio. Neuropharmacol (1995) 19:101–128.
  • CURRY S: Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? Ann. NY Acad. Sci. (2003) 993:69–74.
  • DALEY S, BRAIMAH J, SAILORS: Education to improve stroke awareness and emergent response. The NINDS ft-pa Stroke Study Group. I Neurosci. NUTS. (1997) 29:393–396.

Websites

  • http://www.uic.edu/com/ferne/pdf-stmkeepi0501.pdf MORRIS DL, SCHROEDER E: Stroke Epidemiology 2–9.
  • http://www.allontherapeutics.com/ Stroke.asp ALLON THERAPEUTICS, INC. (2004).
  • http://www.iddb.com/The Investigational Drugs database 1997–2004 Derwent Information Ltd.
  • http://www.strokecenter.org/trials/ TrialDetail.asp?ref=470Stroke Internet Directory/Internet Stroke Center (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.